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Divergent functions of murine Pax3
and Pax7 in limb muscle development
Frédéric Relaix,1 Didier Rocancourt,1 Ahmed Mansouri,2 and Margaret Buckingham1,3
1Centre National de la Recherche Scientifique (CNRS) URA 2578, Department of Developmental Biology, Pasteur Institute,
75724 Paris Cedex 15, France;
2Max-Planck Institute for Biophysical Chemistry, Department of Molecular Cell Biology, D-37077 Gottingen, Germany
Pax genes encode evolutionarily conserved transcription factors that play critical roles in development. Pax3
and Pax7 constitute one of the four Pax subfamilies. Despite partially overlapping expression domains, mouse
mutations for Pax3 and Pax7 have very different consequences. To investigate the mechanism of these
contrasting phenotypes, we replaced Pax3 by Pax7 by using gene targeting in the mouse. Pax7 can substitute
for Pax3 function in dorsal neural tube, neural crest cell, and somite development, but not in the formation of
muscles involving long-range migration of muscle progenitor cells. In limbs in which Pax3 is replaced by
Pax7, the severity of the muscle phenotype increases as the number of Pax7 replacement alleles is reduced,
with the forelimb more affected than the hindlimb. We show that this hypomorphic activity of Pax7 is due to
defects in delamination, migration, and proliferation of muscle precursor cells with inefficient activation of
c-met in the hypaxial domain of the somite. Despite this, overall muscle patterning is retained. We conclude
that functions already prefigured by the single Pax3/7 gene present before vertebrate radiation are fulfilled by
Pax7 as well as Pax3, whereas the role of Pax3 in appendicular muscle formation has diverged, reflecting the
more recent origin of this mode of myogenesis.
[Keywords: Pax3; Pax7; myogenesis; appendicular muscle; evolution; neural tube]
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Gene duplication is a key mechanism for increasing di-
versity and complexity during evolution. Multigene
families arise as a result of successive duplications. One
such family with important functions during develop-
ment codes for the Pax transcription factors (Tremblay
and Gruss 1994). Pax genes are divided into four sub-
families based on sequence similarities (Gruss and Wal-
ther 1992; Noll 1993; Mansouri et al. 1996a). Among
these, the Pax3 and Pax7 genes arose by duplication from
a unique ancestral Pax3/7 gene, and similarities in their
protein sequence and expression pattern reflect this
common origin. All vertebrates examined so far have at
least one of each of these genes. Mammals and birds have
one Pax3 and one Pax7 gene, whereas in the genome of
the teleost fish Danio rerio, one Pax3 gene and at least
four Pax7 variants are found, one of which encodes a
protein with a sequence close to the mammalian Pax7
(Seo et al. 1998). Alternatively spliced forms of Pax3 and
Pax7 have also been reported in mouse and human, al-
though their distribution and function remains poorly
understood (Ziman et al. 1997; Barber et al. 1999).
A unique Pax3/7 gene is found in many vertebrates,
such as in the ascidians (Wada et al. 1996, 1997), in the
chelicerate Tetranychus urticae (Dearden et al. 2002), in
the nematode Caenorhabditis elegans (Hobert and Ru-
vkun 1999) or in Amphioxus (Holland et al. 1999). Be-
cause the genome of Amphioxus, a cephalochordate re-
garded as the closest living invertebrate relative to the
vertebrate, contains only one Pax3/7 gene, it is likely
that the complexity of this Pax subfamily, like that of
other Pax subfamilies, has arisen by gene duplication at
the onset of vertebrate evolution (Holland et al. 1999). In
Drosophila, however, there are three Pax3/7-related
genes (Prd, Gsb, and Gsbn), which probably arose from
independent duplications (Baumgartner et al. 1987; Li
and Noll 1994; Xue et al. 2001).
The spatiotemporal expression pattern of the ascidian
HrPax-37 gene suggests involvement in two distinct de-
velopmental processes: specification of dorsal cell fates
in ectoderm during neurulation, and regional differentia-
tion of the neural tube at later stages (Wada et al. 1996).
Hence, Pax3/7 transcription in the dorsal neural tube is
believed to be the primitive Pax3/7 expression domain,
and indeed, this is a common feature of all species ex-
amined to date. In the mouse, Pax3 and Pax7 are ex-
pressed in the dorsal neural tube, where only Pax3 tran-
scription extends into the dorsal-most region. Splotch
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(Sp) mice, in which a mutation disrupts Pax3 function
(Tremblay and Gruss 1994), have defects in dorsal neural
tube closure (spina bifida and exencephaly). In addition,
analysis of Pax3 and Pax7 double-mutant mice demon-
strates that in the absence of both genes, neural cell fate
is affected such that some cells located dorsally acquire
ventral interneuron identity (Mansouri and Gruss 1998).
Pax3 and Pax7 are also expressed in neural crest,
which is a characteristic of the vertebrate embryo (Le
Douarin and Kalcheim 1999). Neural crest cells emerge
from the dorsal neural tube and migrate throughout the
developing embryo, where they give rise to a range of cell
types, including neurons and glial cells of the peripheral
nervous system and melanocytes. In Pax3-mutant em-
bryos, neural crest cells fail to migrate correctly, result-
ing in either a severe reduction or a complete absence of
neural crest cell derivatives (Auerbach 1954; Franz 1989;
Tremblay et al. 1995). The severity of these defects in-
creases along the rostrocaudal axis, so that no neural
crest derivatives are present in the caudal portion of the
Splotch-mutant embryo (Auerbach 1954). In contrast,
Pax7-deficient mice show anterior (cephalic) neural crest
cell defects (Mansouri et al. 1996b). Amphi-Pax3/7 neu-
ral expression suggests that a population of cells compa-
rable to the premigratory neural crest cells of vertebrates
may have been present in the common ancestor of all
extant chordates (Holland et al. 1999).
The function of the Pax3/7 genes in mesoderm has
been acquired more recently during evolution. Amphi-
oxus, similar to a vertebrate, has segmented axial muscles
and expresses Amphi-Pax3/7 in this muscle lineage, sug-
gesting that Pax3/7 function in mesoderm is present in
cephalochordates (Holland et al. 1999). In the mouse,
Pax3 is expressed in presomitic mesoderm (Schubert
et al. 2001) and then throughout the somite, before be-
coming restricted to the dermomyotome as somites ma-
ture (Goulding et al. 1991). At later stages, Pax3 expres-
sion becomes concentrated in the epaxial (adjacent to the
axis) and hypaxial extremities of the dermomyotome
(see Tajbakhsh and Buckingham 2000). Pax3-mutant em-
bryos have somite defects, including abnormalities in
segmentation (Schubert et al. 2001) as well as loss of the
epaxial and, most notably, hypaxial dermomyotome
(Tajbakhsh and Buckingham 2000). In consequence, the
myotome fails to form correctly. This leads to trunk
muscle defects (Tremblay et al. 1998). Pax3 also has a
critical function in the formation of muscles that depend
on the migration of muscle progenitor cells from the
hypaxial dermomyotome. Most notably, in the absence
of functional Pax3, the limb muscles are absent in
Splotch-mutant embryos (Auerbach 1954; Franz et al.
1993; Bober et al. 1994; Goulding et al. 1994). Pax3 is
required for the activation of c-met (Epstein et al. 1996;
Yang et al. 1996; Relaix et al. 2003), which encodes a
tyrosine kinase receptor, Met, essential for the delami-
nation/migration of muscle progenitor cells (Bladt et al.
1995). Pax3 also has an essential function in regulating
the gene hierarchy which leads to the activation of
MyoD and the formation of skeletal muscle (Tajbakhsh
et al. 1997).
In contrast, no embryonic muscle defect has been de-
scribed in Pax7-mutant mice (Mansouri et al. 1996b),
although Pax7 is expressed in part of the dermomyotome
(Jostes et al. 1990; Tajbakhsh et al. 1997). However Pax7
plays a critical role postnatally when it is required for the
presence of satellite cells, the precursor cells responsible
for the growth and regeneration of skeletal muscle (Seale
et al. 2000). Pax3 is also expressed in satellite cells (Con-
boy and Rando 2002; Buckingham et al. 2003); however,
due to the perinatal death of Pax3 mutants, its role in
adult muscle remains to be elucidated.
Although Pax3 and Pax7 are apparently involved in
different stages of myogenesis, evidence for shared func-
tions comes from the observation that translocations in
humans of both PAX3 and PAX7 with FKHR to give
PAX3–FKHR and PAX7–FKHR fusion proteins lead to
the formation of alveolar rhabdomyosarcomas (ARMSs),
a pediatric tumor of skeletal muscle (Galili et al. 1993;
Davis et al. 1994; Barr 2001).
A key question in understanding the relative functions
of Pax3 and Pax7 is whether these are determined by
biochemical differences between the proteins or by dif-
ferences in the spatiotemporal expression of the two
genes. To address this, we replaced Pax3 by Pax7 by us-
ing gene targeting in the mouse. Analysis of mutant em-
bryos with one or two alleles of Pax7 replacing Pax3 shows
that Pax7 can replace Pax3 in the dorsal neural tube, in
neural crest cells, and in somite development. However,
Pax3 function in the long-range migration of muscle pro-
genitor cells is only partially rescued. Different combi-
nations of the Pax7 replacement alleles act as hypomor-
phic alleles of Pax3 in the formation of limb muscles,
and reveal a multistep requirement for Pax3 activity in
appendicular muscle development. These results provide
new insights into the evolution of the Pax3/7 functions.
Results
Pax3 and Pax7 expression in normal
and mutant embryos
The expression domains of Pax3 and Pax7 in the mouse
embryo were compared, using mice in which Pax3 (Re-
laix et al. 2003) as well as Pax7 (Mansouri et al. 1996b)
genes have been targeted with nLacZ and LacZ reporter
genes, respectively. X-Gal staining (Fig. 1A–H) of normal
and mutant embryos was complemented by in situ hy-
bridization of transcripts from the endogenous Pax genes
(Fig. 1I–Q). In thoracic somites, Pax3 is expressed through-
out the dermomyotome, with the strongest expression
observed in the hypaxial epithelium (Fig. 1A,K; Relaix
et al. 2003). In Pax3-mutant embryos, the somites are
reduced mainly in the hypaxial, but also in the epaxial
domains, and somite segmentation is perturbed (Fig. 1B;
Relaix et al. 2003). Pax7 is also expressed in the dermo-
myotome (Fig. 1C,L); however, this expression is mainly
restricted to the central region and is excluded from the
epaxial and hypaxial extremities, which strongly express
Pax3 (Fig. 1, cf. L and K). In contrast to the situation in
chicken embryos (Marcelle et al. 1995), Pax7 transcripts
are not detected in muscle progenitor cells migrating to
Replacement of Pax3 by Pax7
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the limb, which express Pax3 as shown at embryonic day
10.5 (E10.5; Fig. 1, cf. O and N). In the embryonic limb,
Pax7 transcripts are first detected at E11.5 in the proxi-
mal limb (Fig. 1P) and then by E12.5 in more distal limb
muscles as well (Fig. 1Q). In Pax7 mutants, limb muscles
are present (Fig. 1G,H) and Pax7-expressing cells show a
normal distribution in the somite (Fig. 1C,D). Trunk
muscles develop normally (Fig. 1G,H). Pax7, unlike
Pax3, is expressed in the branchial arches (Fig. 1I,J) and
later in facial muscles (Fig. 1G,H), some of which derive
from muscle precursor cells in the arches. In Pax7-mu-
tant mice, facial muscles do not appear to be affected
(Fig. 1H), and indeed, further regulators intervene spe-
cifically in the formation of muscles derived from the
arches (Lu et al. 2002).
Pax3 and Pax7 are also expressed in the dorsal neural
tube, where, unlike Pax3 (Fig. 1L), Pax7 is excluded from
the dorsal most domain (Fig. 1K). Embryos in which both
alleles of Pax3 have been targeted with nLacZ have de-
fects in neural tube closure (Fig. 1F). As in the case of the
spontaneous Sp mutation (Auerbach 1954; Epstein et al.
1993), spina bifida is observed with a frequency ap-
proaching 100%, whereas exencephaly is more frequent
(65%) than in Sp-mutant embryos (∼40%). Pax7-mutant
embryos do not show neural tube defects (Fig. 1D).
Loss of function in critical developmental genes can
lead to up-regulation of closely related factors as a com-
pensation mechanism, as in the myogenic lineage, in
which MyoD-mutant mice up-regulate Myf5 (Rudnicki
et al. 1992). In Pax3-deficient somites, Pax7 is not up-
(Figure 1 legend on facing page)
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regulated, and its expression is further reduced due to
cell death in the absence of Pax3 (Fig. 1J,M). In the neural
tube also, we detect no significant change in Pax7 ex-
pression (Fig. 1M; Supplementary Fig. S1). This is in con-
trast to a previous report for Sp embryos, in which up-
regulation of Pax7 was described (Borycki et al. 1999).
This may reflect differences in genetic background or
differences between the targeted nLacZ allele and the
Sp alleles from which a truncated form of Pax3 may
still be generated, potentially affecting Pax7 levels. Dif-
ferences in the frequency of exencephaly may reflect
this. We conclude that there is no change in the spatio-
temporal expression pattern of Pax7 in the absence of
Pax3, and we do not detect major differences in expres-
sion levels, suggesting that the two genes are indepen-
dently regulated.
To determine if Pax3 and Pax7 have similar transcrip-
tional activities, we compared the expression of
Pax3nLacZ/+ and Pax7LacZ/+ with that of a Pax3 transcrip-
tional reporter mouse line, P34TKZ (Fig. 1R–T; Relaix
et al. 2003). At E11.5, nLacZ transcripts are found at
all sites of Pax3 and Pax7 expression (Fig. 1, cf. R and S
and T). Notably, P34TKZ expresses nLacZ in head
muscles, in which Pax7 but not Pax3 transcripts are de-
tected (Fig. 1R–T, arrowhead). These results suggest that
Pax7, similarly to Pax3, acts as a transcriptional activa-
tor in vivo.
Strategy for the replacement of Pax3 by Pax7
To investigate the functional difference between these
factors, we replaced Pax3 by Pax7, using gene targeting
in the mouse. The targeting strategy is outlined in Figure
2A and B. We first generated the Pax3DsRed(Pax7–ILZ) al-
lele (Fig. 2A,B). The construct replaces the coding region
in the first Pax3 exon and deletes the splice donor site to
ensure that no functional Pax3 protein is made from the
targeted locus (similarly to the previously reported
Pax3(PAX3–FKHR–IRESnLacZ) allele, see Relaix et al. 2003).
The Pax3Pax7–IRESnLacZ allele (abbreviated Pax3Pax7–ILZ)
was then generated by crossing the Pax3DsRed(Pax7–ILZ)
allele with a transgenic line driving ubiquitous expres-
sion of the Cre recombinase (Lallemand et al. 1998). This
allele contains a mouse Pax7 coding sequence (Seale
et al. 2000) followed by an IRESnLacZ reporter gene and
is used in the studies presented here. The Pax3Pax7–ILZ/+
adult mice are viable and fertile and do not present the
pigmentation phenotype of Pax3 heterozygous mice
(Auerbach 1954), suggesting that Pax7 can complement
Pax3 activity in migration of the neural crest cells, which
give rise to melanocytes. The Pax3DsRed(Pax7–ILZ)/+ em-
bryos presented the pigmentation phenotype of Pax3 (Sp)
heterozygous mice, and when crossed to generate homo-
zygous embryos, mutant embryos presented Pax3-mu-
tant defects (such as failure of neural tube closure, defi-
Figure 1. Despite expression in partially overlapping domains, Pax7 does not rescue defects in Pax3-mutant embryos. (A,B) Pax3
expression at E10.5 revealed by X-Gal staining of Pax3nLacZ/+ (A) and Pax3nLacZ/nLacZ (B) embryos. (A) Normal Pax3 expression is
observed in somites (arrowhead), muscle progenitor cells migrating to the limb (black arrow), hypoglossal chord (red arrow), frontonasal
processes, and dorsal neural tube. (B) Pax3-mutant embryos have somite defects with abnormal segmentation and epaxial and hypaxial
truncation (arrowhead), lack of migrating precursor cells to the limbs (black arrow) and hypoglossal chord (red arrow), and failure of
dorsal neural tube closure (exencephaly and spina bifida). (C,D) Pax7 expression at E10.5 revealed by X-Gal staining of Pax7LacZ/+ (C)
and Pax7LacZ/LacZ (D) embryos. (C) Pax7 expression is detected in somites (arrowhead), frontonasal processes, and the neural tube, but
not in the muscle progenitor cells migrating to the limb (black arrow) or in the hypoglossal chord (red arrow). (D) Pax7-deficient
embryos do not present any obvious defects at sites of Pax7 expression. (E,F) Expression of Pax3 at E13.5 revealed by X-Gal staining
in Pax3nLacZ/+ (E) and Pax3nLacZ/nLacZ (F) embryos. (E) Pax3 expression is observed at this stage in the dorsal neural tube, limb, cervical,
and body muscles. (F) Pax3-mutant embryos have defects in neural tube closure (here striking spina bifida), lack of limb muscles, and
reduced and disorganized cervical and trunk muscles. (G,H) Expression of Pax7 at E13.5 revealed by X-Gal staining in Pax7LacZ/+ (G)
and Pax7LacZ/LacZ (H) embryos. In contrast to Pax3-deficient embryos, lack of Pax7 does not lead to any obvious defect despite
expression of Pax7 at this stage in the muscle masses of the limbs as well as the trunk. Head muscles do not express Pax3 (E,
arrowhead), but express Pax7, clearly seen in mouse embryos with two Pax7LacZ alleles (H, arrowhead) despite the absence of Pax7.
(I,J) Pax7 expression at E10.5 in Pax3nLacZ/+ (I) and Pax3nLacZ/nLacZ (J) embryos revealed by in situ hybridization. (I) In Pax3nLacZ/+
embryos, Pax7 is expressed in somites and in the branchial arches (arrowheads), in cells that will later form facial muscles, but not
in limb muscle progenitor cells (arrow). Pax7 transcripts are also present in frontonasal processes and in the dorsal neural tube. (J) In
Pax3nLacZ/nLacZ-mutant embryos, Pax7 expression is reduced in the somite, reflecting the loss of cells, but is not affected in the
branchial arches, where Pax3 is not expressed (see A). (K) Pax3 expression in the thoracic region at E10.5 in Pax3nLacZ/+ embryos
revealed by in situ hybridization. Pax3 is transcribed in the dorsal neural tube (blue arrowhead) and throughout the dermomyotome,
with stronger expression in the epaxial and hypaxial domains (black arrowheads). (L,M) Pax7 expression in the thoracic region of
Pax3nLacZ/+ (L) and Pax3nLacZ/nLacZ (M) embryos at E10.5 revealed by in situ hybridization. (L) Pax7 is transcribed in the central
dermomyotome, but not in the epaxial and hypaxial-most regions in heterozygote embryos (black arrowheads). In the dorsal neural
tube, Pax7 transcripts are absent from the dorsal-most region (blue arrowheads). (M) In Pax3-mutant embryos, Pax7 expression in the
somite is severely reduced due to loss of cells (black arrowhead), whereas neural tube expression seems unaffected (blue arrowheads).
(N) Pax3 expression in muscle progenitor cells in the forelimb of E10.5 embryos revealed by in situ hybridization. (O–Q) Pax7
expression in the forelimb of E10.5 (O), E11.5 (P), and E12.5 (Q) embryos monitored by in situ hybridization. Pax7 transcripts are first
detected at E11.5 in proximal muscle masses (P) and then detected in the more distal limb muscles at E12.5 (Q). (R–T) Expression of
Pax3 (R), Pax7 (S), and a Pax3 transcriptional reporter transgene (T; P34TKZ; Relaix et al. 2003) at E11.5 revealed by X-Gal staining.
The black arrowhead shows expression of Pax7 and P34TKZ, but not Pax3, in head muscles, suggesting that Pax7 acts, similarly to
Pax3, as a transcriptional activator in vivo.
Replacement of Pax3 by Pax7
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Figure 2. Strategy and specificity of Pax7
targeting into the Pax3 locus. (A) Sche-
matic diagram of the Pax3 locus and tar-
geting construct. The construct contains
2.4 kb and 4 kb, respectively, of 5 and 3
Pax3 genomic sequence. A floxed DsRed
reporter gene followed by a FRT site and
then a puromycin-pA (Puro) selection
marker replaces the coding sequence in
exon 1 of Pax3, followed by a dicistronic
cassette containing 1.8 kb of the murine
Pax7 cDNA comprising the whole coding
region, followed by an IRESnLacZ cas-
sette surrounded by FRT sites and a pA
signal. A counter-selection cassette en-
coding the A subunit of Diphtheria Toxin
(DTA) was inserted at the 5 end of the
vector. The probes and restriction en-
zymes are indicated, with the size of the
resulting wild type and recombined re-
striction fragments. (B) Schematic dia-
gram of the Pax3DsRed(Pax7–ILZ) and
Pax3Pax7–ILZ alleles. After homologous re-
combination in embryonic stem (ES) cells,
Pax7–IRESnLacZ expression from the
Pax3DsRed(Pax7–IRESnLacZ) allele is blocked
by the floxed DsRed-FRT-puromycin-pA
cassette and is therefore conditional to re-
moval by crossing with a Cre mouse (Lal-
lemand et al. 1998). This generates the
Pax3Pax7–IRESnLacZ allele (abbreviated
Pax3Pax7–ILZ) with the Pax7–FRT–IRESn-
LacZ–FRT-pA preceded by a single LoxP
site. Pax3Pax7–ILZ/+ mice are viable and fer-
tile. The probes and restriction enzymes
are indicated, with the size of the result-
ing wild type and recombined restriction
fragments. (C–K) Immunohistochemistry
on transverse sections of neural tube (C–
H) and thoracic somites (I–K) from E10.5
Pax3nLacZ/+ (C,C,F,F,I,I), Pax3Pax7–ILZ/+
(D,D,G,G,J,J), and Pax3Pax7–ILZ/Sp (E,E,
H,H,K,K) embryos using antibodies rec-
ognizing -Gal (C–K), Pax3 (C–K), and
Pax7 (F–H). Note Pax3-specific staining
in the dorsal-most neural tube (C, arrow-
head) and dorsal root ganglia (C, arrow),
whereas Pax7 is excluded from these do-
mains (F, arrowhead and arrow). In
Pax3Pax7–ILZ/+ (G) and Pax3Pax7–ILZ/Sp (H)
embryos, Pax7 is now expressed in these
structures (dorsal neural tube, arrowhead;
dorsal root ganglia, arrow). Whereas Pax3
is expressed in Pax3nLacZ/+ (C,I) and
Pax3Pax7–ILZ/+ (D,J), no expression is de-
tected in Pax3Pax7–ILZ/Sp embryos, either
in the neural tube and dorsal root ganglia
(E) or in somites (K).
Relaix et al.
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cient neural crest cell migration, lack of dorsal root gan-
glia and limb muscles), suggesting that no functional
Pax3 is generated from this allele.
Because a low level of transcript was detected using a
Pax3 3 probe in the Pax3Pax7–ILZ/Pax7–ILZ embryos
(Supplementary Fig. S2A,B), possibly due to a cryptic pro-
moter or splice site, we used Pax3- and Pax7-specific
antibodies to verify that the replacement strategy had
worked. In a preliminary experiment, we tested the Pax3
antibody on Pax3nLacZ/nLacZ embryos and found that,
although a 3UTR transcript was also observed (Sup-
plementary Fig. S2C,D), no Pax3 protein was made
(Supplementary Fig. S2E–J). This finding is consistent
with the loss-of-function phenotype observed in the
Pax3nLacZ/nLacZ-mutant embryos (Fig. 3E). We then per-
formed coimmunostaining with the Pax3 and Pax7 anti-
bodies, which recognize a -COOH region specific to each
protein, on E10.5 Pax3Pax7–ILZ/Sp embryos, in which one
Pax7 knock-in allele is expressed and there is no func-
tional Pax3 allele. The results, presented in Figure 2C–K,
confirm that no Pax3 protein is detected from the
Pax3Pax7–ILZ allele, either in the neural tube and dorsal
root ganglia (Fig. 2, cf. E, and E,C) or in the somites
(Fig. 2, cf. K, and K,I). Furthermore Pax7 is now detect-
Figure 3. Embryos in which Pax7 replaces Pax3 have defects in limb muscle formation, but other aspects of the Pax3 mutation are
rescued. The number of Pax7, Pax3, or Pax3-mutant (−) alleles replacing the two Pax3 endogenous alleles is indicated below the panels.
Expression and phenotypes at E11.5 in Pax3nLacZ/+ (A,F,K), Pax3Pax7–ILZ/+ (B,G,L), Pax3Pax7–ILZ/Pax7–ILZ (C,H,M), Pax3Pax7–ILZ/Sp (D,I,N),
and Pax3nLacZ/nLacZ (E,J,O) embryos are revealed by X-Gal staining. Whole embryos are shown in A–E, thoracic regions in F–J, and
anterior somites and forelimb in K–O. Pax7 can functionally compensate for Pax3 deficiencies in dorsal neural tube closure (A–E, red
arrows), somite formation (F–J, black arrow), neural crest cells, and derivatives, such as melanocytes, cranial, and dorsal root ganglia
(K–O, blue arrow). However, forelimb muscles are not present in Pax3Pax7–ILZ/Sp embryos (D,N, black arrow), similarly to Pax3nLacZ/nLacZ
embryos (E,O, black arrow). Homozygote Pax3Pax7–ILZ/Pax7–ILZ embryos (C,M) have an intermediate phenotype with severe reduction
in forelimb musculature compared with the control Pax3nLacZ/+ embryos (A,K). Hindlimb muscles are apparently less affected,
although reduced in Pax3Pax7–ILZ/Sp embryos (D, see Fig. 5).
Replacement of Pax3 by Pax7
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ed at sites where Pax3, but not Pax7, is normally ex-
pressed, such as the dorsal-most region of the neural
tube or the dorsal root ganglia of the peripheral nervous
system (Fig. 2, cf. G,H, and F) as well as in the somi-
tic hypaxial dermomyotome (data not shown). From
these data we conclude that the replacement strategy is
working.
Expression of the Pax3Pax7–ILZ allele
and resulting phenotypes
The Pax3Pax7–ILZ allele permit analysis of the expression
of the Pax7 coding sequences targeted to Pax3 due to the
presence of the IRESnLacZ reporter gene, as illustrated
in Figure 3. Comparison of the Pax3Pax7–ILZ allele with
the Pax3nLacZ reporter line, which contains an nLacZ
reporter gene targeted to exon 1 of Pax3 (F. Relaix and
M. Buckingham, in prep.) led us to conclude that expres-
sion of the Pax3Pax7–ILZ allele is identical (Fig. 3A,B). The
results shown in Figure 3 demonstrate that Pax7 is able
to replace Pax3 function in dorsal neural tube closure
(avoiding exencephaly and spina bifida; Fig. 3A–E), in
the formation of neural crest cell derivatives in the
trunk, such as melanocytes, or cranial and spinal ganglia
(Fig. 3K–O) and in somitogenesis, both in somite seg-
mentation and in hypaxial and epaxial dermomyotome
development (Fig. 3F–J; cf. Fig. 2K and Supplementary
Fig. S2H). However, X-Gal staining of Pax3Pax7–ILZ/Sp
embryos reveals a complete lack of forelimb muscles,
whereas Pax3Pax7–ILZ/Pax7–ILZ embryos have a reduction
(Fig. 3K–O). This suggests that Pax7 cannot compensate
for Pax3 function in forelimb muscle development.
A hallmark of the Pax gene family is sensitivity to gene
dosage (Tremblay and Gruss 1994). In the Pax3Pax7–ILZ/Sp
embryos (in which one copy of Pax7 replaces both Pax3
alleles), there was no melanocyte phenotype, and the
spina bifida phenotype was not observed at a higher fre-
quency than in Pax3 heterozygote embryos. This sug-
gests that the Pax7 allele is expressed at a comparable
level to that of the endogenous Pax3 gene. This was
confirmed by comparing the intensity of expression of
the IRESnLacZ in the Pax3Pax7–ILZ/+ allele to that of
the Pax3IRESnLacZ and Pax3nLacZ/+ alleles (Fig. 3; Relaix
et al. 2003). We therefore conclude that the appendic-
ular muscle defects observed in Pax3Pax7–ILZ/Sp and
Pax3Pax7–ILZ/Pax7–ILZ embryos are due to Pax7 function
rather than to a reduced level of expression of this allele.
Impaired muscle formation in the limbs
of Pax3Pax7–ILZ/Pax7–ILZ embryos
To further investigate limb muscle defects when Pax7 re-
places Pax3, we compared transverse sections of forelimbs
from Pax3Pax7–ILZ/+ and Pax3Pax7–ILZ/Pax7–ILZ embryos at
E11.5 (Fig. 4A,B). In homozygote Pax3Pax7–ILZ/Pax7–ILZ
limbs, the distal ventral muscles are lacking (Fig. 4B,
black arrow), whereas distal dorsal muscles are reduced
(Fig. 4B, blue arrow). Furthermore, the proximal muscle
masses are reduced and incorrectly patterned (Fig. 4A,B,
arrowheads).
Figure 4. Forelimb muscle development is impaired in
Pax3Pax7–ILZ/Pax7–ILZ embryos. (A,B) X-Gal staining of transverse
sections of Pax3Pax7–ILZ/+ (A) and Pax3Pax7–ILZ/Pax7–ILZ (B) em-
bryos at E11.5. At this stage, the ventral distal muscles are
lacking (black arrow), the dorsal distal muscle masses are re-
duced (blue arrow), and some proximal muscle masses are miss-
ing (arrowheads) in the Pax3Pax7–ILZ/Pax7–ILZ embryos (B) com-
pared with the Pax3Pax7–ILZ/+ embryos (A), which are indistin-
guishable from controls. (C–H) Immunohistochemistry on
proximal to distal transverse sections of forelimb from
Pax3Pax7–ILZ/+ (C,E,G) or Pax3Pax7–ILZ/Pax7–ILZ (D,F,H) fetuses at
E15.5 using an antibody recognizing striated muscle myosin
heavy chains shows a strong reduction which is more pro-
nounced distally, both in the dorsal (which are the most af-
fected) and ventral muscle masses in the homozygote mutant
(D,F,H) compared with the heterozygote control (C,E,G).
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To evaluate the consequence of these defects at later
stages, we analyzed transverse sections of the forelimb at
E15.5 along the proximal to distal axis. Staining with an
anti-myosin heavy chain antibody reveals major reduction
and loss in muscle masses in the Pax3Pax7–ILZ/Pax7–ILZ
fetuses compared with controls (Fig. 4C–H). This follows
a proximal to distal gradient: Proximally, dorsal muscle
masses (extensor muscles) are lacking or severely re-
duced and ventral masses (flexor muscles) are reduced
(Fig. 4C,D); distally, all dorsal muscles masses and al-
most all ventral masses are lacking (Fig. 4G,H).
Forelimb muscles are absent in embryos in which only
one Pax7–ILZ allele replaces Pax3 (Fig. 3D,N). In situ
hybridization with a MyoD probe at E11.5 confirms that
myogenic cells are absent from the forelimbs of
Pax3Pax7–ILZ/Sp embryos (Fig. 5, cf. B and A), whereas
muscle masses in the trunk or head express MyoD nor-
mally. At E13.5, this is also evident (Fig. 5D) when the
nLacZ reporter gene in the forelimb is only expressed in
cells of the peripheral nervous system, derived from neu-
ral crest, which is rescued by Pax7 (Fig. 5F). Patterning of
the peripheral nervous system appears normal in the ab-
sence of any muscle masses in the forelimb of these mu-
tant mice.
Whereas Pax3Pax7–ILZ/Pax7–ILZ embryos do not have a
hindlimb phenotype, muscle formation is abnormal in
Pax3Pax7–ILZ/Sp embryos (Fig. 3A), as indicated by MyoD
in situ hybridization at E11.5 (Fig. 5B). At E13.5 (Fig.
5D,H), hindlimb muscles masses are reduced and distal
muscle masses of the palm are lacking in Pax3Pax7–ILZ/Sp
fetuses (Fig. 5, cf. H and G).
One copy of Pax7 cannot replace Pax3 function in the
delamination/migration of muscle progenitor cells
Limb muscles are formed by cells that delaminate from
the hypaxial dermomyotome of somites facing the limbs
and then migrate into the limb bud. We therefore inves-
tigated if the migration of these muscle progenitor cells
is normal in the hindlimbs of Pax3Pax7–ILZ/Sp embryos,
and found that distal cells are absent (Fig. 5I,J, black ar-
row). This correlates with the more pronounced effect of
the mutant in the distal muscles of the limb.
Muscle progenitor cells initiate migration around the
20-somite stage (E9.5) to the forelimb and hypoglossal
chord. After delamination, the cells rapidly invade the
limb bud (∼22 somites in the mouse embryo; Fig. 6A,C).
In Pax3Pax7–ILZ/Sp embryos, however, these cells leave
the somite in the ventral region but do not migrate fur-
ther into the limb field. At E10.25 (31 somites) in control
embryos, migration to the forelimb is virtually complete
(Fig. 6E,G). In Pax3Pax7–ILZ/Sp embryos, labeled cells are
present ventrally, but myogenic progenitor cells have
not invaded the limb bud (Fig. 6F,H). These results sug-
gest that Pax7 can partially fulfill the Pax3 requirement
for delamination, but one replacement allele of Pax7
cannot compensate for Pax3 function in migration (see
Fig. 8, below).
Muscles of the pharynx and some tongue muscles are
also derived from long-range migrating muscle progeni-
Figure 5. Distal hindlimb defects in Pax3Pax7–ILZ/Sp embryos.
(A,B) MyoD in situ hybridization shows that myogenic cells
are specifically lost in the forelimb of Pax3Pax7–ILZ/Sp embryos
(B, white arrow), whereas hindlimb muscle masses are slightly
reduced (green arrowhead). (A) Myotomal expression of MyoD
(black arrow) like that in other trunk and head muscles is ap-
parently not affected when compared to the control. (C,D) X-Gal
staining of E13.5 Pax3Pax7–ILZ/+ (C) or Pax3Pax7–ILZ/Sp (D) em-
bryos shows lack of forelimb muscles (black arrow) and reduced
hindlimb muscles (red arrow) in a Pax3Pax7–ILZ/Sp embryo (D),
compared with the control embryo (C). (E,F) X-Gal staining of
the ventral forelimb of Pax3Pax7–ILZ/+ (E) or Pax3Pax7–ILZ/Sp (F)
fetuses at E13.5 shows that, although muscles are completely
absent from the Pax3Pax7–ILZ/Sp forelimb (red arrowhead), ex-
pression of Pax3 in the peripheral nervous system is not per-
turbed (black arrowhead). (G,H) X-Gal staining of Pax3Pax7–ILZ/+
(G) or Pax3Pax7–ILZ/Sp (H) in ventral hindlimbs at E13.5 shows
loss of muscle masses, particularly evident for distal palm
muscles in the mutant embryo (H, black arrow), compared with
the control (G). (I,J) Dorsal view of the muscle progenitor cells
that migrate into the hindlimb at E10.5 in Pax3Pax7–ILZ/+ (I) or
Pax3Pax7–ILZ/Sp (J) embryos. Lack of distal cells in the mutant
embryos is shown by a black arrow (J, cf. I).
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tor cells. This stream of cells (hypoglossal chord) origi-
nates from the cervical and occipital somites and mi-
grates through the pharyngeal region between E9.75 and
E11.5. Pax3 is also required for its formation (Tajbakhsh
and Buckingham 2000). At E10.5, Pax3Pax7–ILZ/Sp em-
bryos have a severely reduced hypoglossal chord (Fig. 6,
cf. J and I). This is consistent with the limb results,
which suggest that Pax7 is not functionally equivalent to
Pax3 for the development of muscles that require long-
range migration of muscle progenitor cells. Identical re-
sults were obtained for the cells migrating to the dia-
phragm anlagen at the level of the ventral forelimb (data
not shown). Impairment of diaphragm develop-
ment probably underlies the perinatal lethality of
Pax3Pax7–ILZ/Sp and Pax3Pax7–ILZ/Pax7–ILZ mouse lines
(from 12 and 15 litters, respectively, there were no live
neonates).
Expression of c-met is impaired
in Pax3Pax7–ILZ/Sp embryos
Pax3 controls delamination and migration of muscle pro-
genitor cells through the direct transcriptional control of
c-met, which encodes a receptor tyrosine kinase essen-
tial for these processes (Bladt et al. 1995; Epstein et al.
1996; Yang et al. 1996; Relaix et al. 2003). We there-
fore investigated whether c-met expression is detected
in embryos in which Pax7 replaces Pax3. At E9.75, in
Pax3Pax7–ILZ/Sp embryos, c-met is activated in the ep-
axial dermomyotome but not in the hypaxial dermo-
myotome of cervical somites (Fig. 6M,N). At E10.5, c-
met expression is not detectable in the forelimb of
Pax3Pax7–ILZ/Sp embryos and is reduced in the hypaxial
somites at the thoracic level (Fig. 6O,P, red arrowhead),
whereas epaxial expression of c-met appears normal (Fig.
6O,P, yellow arrowhead). In hindlimbs, in which some
migration of myogenic progenitor cells occurs in
Pax3Pax7–ILZ/Sp embryos, c-met expression is detectable,
although severely reduced (Fig. 6O–P). Unlike Pax3-
mutant mice, in which the hypaxial dermomyotome is
missing, the Pax3Pax7–ILZ/Sp allele rescues this pheno-
type (Fig. 6K,L), indicating that Pax7 can substitute for
the antiapoptotic function of Pax3 (Borycki et al. 1999;
Pani et al. 2002), as shown by labeling with an antibody
to the activated form of Caspase-3, which marks apopto-
tic cells (Fig. 6R–T). This is in contrast to the effect on
c-met activation. The oncogenic gain-of-function form of
Pax3, PAX3–FKHR, has been shown previously to trans-
activate the human c-met promoter (Epstein et al. 1996).
We therefore investigated whether Pax7 was able to
transactivate the human c-met promoter region, because
the putative Pax3-binding sites are not conserved in the
Figure 6. Reduced delamination and aberrant migration of muscle progenitor cells correlate with defective c-met expression in
Pax3Pax7–ILZ/Sp embryos. (A,B) X-Gal staining of E9.5 (22 somites) Pax3Pax7–ILZ/+ (A) or Pax3Pax7–ILZ/Sp (B) embryos shows a reduced
number of muscle progenitor cells invading the forelimb bud of Pax3Pax7–ILZ/Sp embryos (B) compared with the control embryo (A). In
contrast neural crest cells in the arches appear normal (black arrows). (C,D) Close-up views (boxed in A,B) of the somites at the
forelimb level in E9.5 (22 somites) Pax3Pax7–ILZ/+ (C) or Pax3Pax7–ILZ/Sp (D) embryos, stained with X-Gal, show delamination but not
migration from the hypaxial region of the somites in Pax3Pax7–ILZ/Sp embryos (D, black arrow) compared with the control embryo (C,
black arrow). Neural crest cell migration from the dorsal neural tube is normal (yellow arrow). (E,F) Close-up views of the somites
opposite to the forelimb in E10.25 (31 somites) Pax3nLacZ/+ (E) or Pax3Pax7–ILZ/Sp (F) embryos, stained with X-Gal, show that in the
mutant embryos, labeled cells are present ventrally to the forelimb (white arrow), but muscle progenitor cells (black arrow) have not
migrated in the limb. (G,H) X-Gal staining of a transverse section from Pax3nLacZ/+ (G) or Pax3Pax7–ILZ/Sp (H) embryos at E10.25 (31
somites) shows accumulation of muscle progenitor cells ventrally to the proximal forelimb of Pax3Pax7–ILZ/Sp embryos (H, arrow)
probably corresponding to cells that will contribute to the diaphragm anlagen as in Pax3nLacZ/+ embryos (G, arrow). (I,J) At E10.5 the
muscle progenitor cells of the hypoglossal chord are strongly reduced and migrate aberrantly in Pax3Pax7–ILZ/Sp embryos (J) compared
with the control Pax3Pax7–ILZ/+ embryos (I). (K,L) X-Gal staining of Pax3Pax7–ILZ/+ (K) or Pax3Pax7–ILZ/Sp (L) embryos at E9.75 (26 somites)
shows a loss of muscle progenitor cells populating the forelimb bud (FL) and hypoglossal chord (blue arrow) in Pax3Pax7–ILZ/Sp embryos
(K) compared with the control embryo (L), whereas the hypaxial dermomyotome is intact in these embryos (yellow arrow). (M,N) In
situ hybridization using a c-met probe shows severely reduced expression of c-met in the hypaxial domain of occipital/cervical somites
(yellow arrowhead) and at the base of the limb bud (blue arrowhead), whereas epaxial expression in the somite is normal (black arrow),
at E9.75 in Pax3Pax7–ILZ/Sp embryos (N) compared with Pax3Pax7–ILZ/+ control embryos (M). (O–P) In situ hybridization using a c-met
probe at E10.5 shows complete loss of c-met transcripts in the hypaxial dermomyotome of somites at the cervical level and in the
forelimb in Pax3Pax7–ILZ/Sp embryos (P, black arrowhead) compared with Pax3Pax7–ILZ/+ control embryos (O, black arrowhead). Reduc-
tion in c-met expression is also observed in the hypaxial dermomyotome of thoracic somites in Pax3Pax7–ILZ/Sp embryos compared with
Pax3Pax7–ILZ/+ control embryos (P, cf. O, red arrowhead). At this stage the epaxial expression of c-met is similar in Pax3Pax7–ILZ/Sp
embryos compared with Pax3Pax7–ILZ/+ control embryos (P, cf. O, yellow arrowhead). In contrast to the forelimb c-met expression is
just detectable in the muscle progenitor cells migrating to the hindlimbs of Pax3Pax7–ILZ/Sp embryos (P, arrow) compared with
Pax3Pax7–ILZ/+ control embryos (O, arrow). (Q) Transactivation of the human c-met promoter by PAX3–FKHR, Pax3-VP16, and
Pax7-VP16 in 293 cells. One microgram of test construct (or empty vector) was cotransfected with 0.2 µg c-metP-TK-nLacZ with 1 µg
RSV-luciferase for normalization. Data show relative -Gal activity 36 h after transfection. Fold induction was calculated with
reference to the activity measured in cells transfected with the expression vector alone. Mean values are given and the standard
deviation indicated for three independent determinations. (R–T) Immunohistochemistry on transverse sections of thoracic somites
from E10.5 Pax3nLacZ/+ (Pax3+/−; R,R), Pax3nLacZ/nLacZ (Pax3−/−; S,S), and Pax3Pax7–ILZ/Sp (T,T) embryos using DAPI staining (R–T),
antibodies recognizing -Gal (R–T) or the active form of Caspase-3 (R–T). Apoptotic -Gal-positive cells that have activated
Caspase-3 are found in the hypaxial somite of Pax3nLacZ/nLacZ (S, arrowhead, also in S,S) but not in control Pax3nLacZ/+ or Pax3Pax7–
ILZ/Sp embryos (R,T). Note the presence of an intact hypaxial epithelial dermomyotome in Pax3Pax7–ILZ/Sp embryos (T,T) compared
with Pax3nLacZ/nLacZ (S,S).
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mouse sequence. Pax3 and Pax7 act in vivo as transcrip-
tional activators (see Fig. 1R–T; Relaix et al. 2003); how-
ever, both proteins on their own are very poor transacti-
vators, probably reflecting a requirement for coactiva-
tors. We found that Pax7-VP16 was able to transactivate
the c-met reporter gene better than was PAX3–FKHR or
Pax3-VP16 (Fig. 6Q). This indicates that the inability of
Pax7 to activate c-met in the hypaxial somite is probably
due to the lack of Pax7-specific coactivator(s). We con-
clude that genes involved in the migration of myogenic
progenitor cells are regulated by Pax3 independently of
other Pax3/7 functions, probably through interaction
with Pax3-specific coactivators.
The role of Pax3 in patterning limb muscles
and in cell proliferation
Pax3Pax7–ILZ/Sp embryos fail to develop forelimb muscles,
and homozygous Pax3Pax7–ILZ/Pax7–ILZ embryos present an
intermediate phenotype, with a reduction of limb mus-
culature (Figs. 3, 4). In these embryos, the onset of the
migratory process is apparently normal, but the number
of delaminating cells is reduced compared with that of
control embryos (Fig. 7A,B). By E10.5, when migration to
the forelimb is complete, in Pax3Pax7–ILZ/Pax7–ILZ em-
bryos the number of muscle precursor cells located in
the forelimb is severely reduced as revealed by whole-
mount X-Gal staining (Fig. 7, cf. D and C, arrow). Histo-
logical examination at this stage reveals an 80% reduc-
tion of myogenic progenitor cells (Fig. 7, cf. F and E),
which tend to accumulate in the dorsal and ventral-most
position in the forelimb bud at this stage (Fig. 7E,F). This
deficit leads to a reduction in muscle masses by E11.5
(Figs. 7G,H, 4A,B). However, strikingly, the muscle cells
are organized in a pattern that mimics normal muscle
development (Figs. 7G,H [arrows], 3K–M). Notably, dis-
tal palm muscles are absent (Fig. 4), although it is clear
that proximal muscle masses are also affected (Fig. 7H).
The overall muscle pattern in Pax3Pax7–ILZ/Pax7–ILZ em-
bryos is very penetrant and almost identical in all em-
bryos examined at this stage.
In the mouse forelimb, myogenesis is initiated around
E10.5 by the activation of Myf5, followed a few hours
later by MyoD (Tajbakhsh et al. 1996). Because MyoD
is a potential Pax3 target (Tajbakhsh et al. 1997; Relaix
et al. 2003), we performed MyoD in situ hybridization,
which revealed that MyoD expression is normal in the
remaining muscle masses in Pax3Pax7–ILZ/Pax7–ILZ em-
bryos (Fig. 7I,J).
The reduction in limb musculature observed in the
Pax3Pax7–ILZ/Pax7–ILZ embryos is due to a reduction in
the migration of muscle progenitor cells, but it may
also reflect a reduction in their proliferation or, alter-
natively, an increase in apoptosis. We found no signifi-
cant apoptosis in the limb muscle masses of E11.5
Pax3Pax7–ILZ/Pax7–ILZ embryos compared with the con-
trol (Fig. 7K–N). We therefore examined the proliferation
of these cells in Pax3Pax7–ILZ/Pax7–ILZ embryos compared
with control embryos by scoring the percentage of -
galactosidase (-Gal)-positive cells (which marks all
the muscle progenitor cells at this stage) within the
forelimb that are in mitosis, by labeling with an antibody
directed against the Ser 10 phosphorylated form of
histone H3. We found that at E11.5 the forelimbs of
Pax3Pax7–ILZ/Pax7–ILZ embryos contained 2.9% of -
Gal/H3-P double-positive cells, versus 4.7% in the con-
trol Pax3Pax7–ILZ/+ embryos (Fig. 7O). From this, we con-
clude that the proliferative capacity of muscle progenitor
cells is reduced by 40% when two Pax7 alleles replace a
single Pax3 allele.
In addition to the role of Pax3 in the hypaxial dermo-
myotome, which is replaced by Pax7, Pax7 only partially
fulfills the function of Pax3 in the delamination, migra-
tion, and proliferation of limb muscle progenitor cells and
in the establishment of individual muscle masses (Fig. 8).
Discussion
Pax3 and Pax7 proteins are functionally equivalent
in somite, neural tube, and neural crest development
Although Pax3 and Pax7 are expressed in partially over-
lapping domains in the mouse embryo, mice mutated in
each of these genes have very contrasting phenotypes. To
investigate whether these are caused by differences in
temporal expression or biochemical activity of the Pax3
and Pax7 proteins, we replaced Pax3 by a Pax7 coding
sequence, using gene targeting in the mouse. Our data
show that Pax7, generated from one Pax3 allele, can
functionally compensate for Pax3 at all sites where it is
expressed, with the exception of the muscle progenitor
cells, which migrate from the somites to form distant
muscle masses such as those in the limbs. Therefore,
differences in spatiotemporal expression probably ac-
count for phenotypic differences between these two
mouse mutants in the dorsal neural tube, in neural crest
and its derivatives, and in somites and trunk muscula-
ture. The function of Pax3/7 in the dorsal neural tube,
neural crest, and somite probably existed before the
Pax3/7 gene duplication at the onset of vertebrate evo-
lution.
Of the three other Pax subfamilies in vertebrates—
Pax1/9, Pax4/6, and Pax2/5/8—a previous report of gene
replacement of Pax2 by Pax5 showed that these tran-
scription factors have maintained equivalent biochemi-
cal functions, because Pax5 was able to compensate
functionally for all Pax2 functions in the mouse
(Bouchard et al. 2000). Moreover, replacement of closely
related genes in families of transcription factors that play
important regulatory roles in development—such as the
bHLH transcription factors myogenin and Myf5 (Wang
et al. 1996), or MesP1 and MesP2 (Saga 1998), the ho-
meobox transcription factors Otx1 and Otx2 (Suda et al.
1999), or En1 and En2 (Hanks et al. 1995), the components
of the AP-1 transcription factor Jun and JunB (Passegue
et al. 2002), or Fra-1 and c-Fos (Fleischmann et al. 2000)—
has been reported to suggest conservation of function.
However, gene replacement of more distantly related
transcription factors, such as the homeobox-containing
proteins Emx2 or Otx2 (Suda et al. 2001) or the proneural
Relaix et al.
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Figure 7. Impaired muscle progenitor cell proliferation and patterning of muscle masses in Pax3Pax7–ILZ/Pax7–ILZ embryos. (A,B) X-Gal
staining of the anterior somites of Pax3Pax7–ILZ/+ (A) or Pax3Pax7–ILZ/Pax7–ILZ (B) embryos at E9.75 (26 somites) shows reduced numbers
of muscle progenitor cells invading the forelimb (red arrow) and the hypoglossal chord (black arrow) in Pax3Pax7–ILZ/Pax7–ILZ embryos
(B) compared with the control embryo (A). However, anterior neural crest cell migration (blue arrowhead) appears normal. (C,D) X-Gal
staining of the forelimb of Pax3Pax7–ILZ/+ (C) or Pax3Pax7–ILZ/Pax7–ILZ (D) embryos at E10.5 shows severe reduction of muscle precursor
cells once the migration process is achieved (arrow). (E,F) X-Gal staining of transverse sections (plane of section shown in C,D) of the
forelimb of Pax3Pax7–ILZ/+ (E) or Pax3Pax7–ILZ/Pax7–ILZ (F) embryos at E10.5 shows that the muscle progenitor cells are reduced by ∼80%
and accumulate in the dorsal and ventral-most part of the limb bud (black and red arrowheads, respectively). (G,H) X-Gal staining of
the forelimb of Pax3Pax7–ILZ/+ (G) or Pax3Pax7–ILZ/Pax7–ILZ (H) embryos at E11.5. Muscle masses that are reduced in the mutant embryo
are indicated by a black arrow, whereas muscle masses that are undetectable are labeled by an asterisk. (I,J) In situ hybridization using
a MyoD probe on the forelimb of Pax3Pax7–ILZ/+ (I) or Pax3Pax7–ILZ/Pax7–ILZ (J) embryos at E11.5. Although muscle masses are reduced
in size and number, expression of MyoD is detectable in the mutant forelimb (H) compared with the control (G). (K–N) Immunohis-
tochemistry on transverse sections of the forelimb (K–N) and dorsal root ganglia (K–N) of E11.5 Pax3Pax7–ILZ/+ (K,K,M,M) and
Pax3Pax7–ILZ/Sp (L,L,N,N) embryos using antibodies recognizing desmin (pink; with DAPI staining in blue; K–L) and the active form
of Caspase-3 which marks apoptotic cells (bright green; with desmin in red, M–N). At this stage, whereas apoptotic cells can be found
in the dorsal root ganglia of both Pax3Pax7–ILZ/+ (M) and Pax3Pax7–ILZ/Sp (N) embryos, no apoptosis is detected in the limb muscle
masses of Pax3Pax7–ILZ/+ (M) and Pax3Pax7–ILZ/Sp (N) embryos. (O) Proliferation of muscle precursor cells is reduced in the forelimb of
Pax3Pax7–ILZ/Pax7–ILZ compared with Pax3Pax7–ILZ/+ embryos at E11.5. Coimmunostaining with an antibody that recognizes the phos-
phorylated form of histone H3 Ser 10 in -Gal-positive cells gave an indication of cell proliferation. The mean percentage of -Gal/
phosphorylated histone H3 (Ser 10) double-positive cells as well as the standard deviation are indicated for four independent deter-
minations.
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genes Mash1 and Ngn2 (Parras et al. 2002), demonstrated
that these proteins are not functionally equivalent, and
that antiquity in evolution and divergence of biochemi-
cal functions are directly linked.
Pax3 and Pax7 function in neural crest
and nervous system development
Pax7-mutant mice have subtle embryonic abnormalities
in facial ossification that almost disappear on a mixed
genetic background. Defects in anterior neural crest cells
are believed to account for this phenotype (Mansouri
et al. 1996b). Splotch mice have no facial phenotype,
although, in contrast, a function for Pax3 has been de-
scribed in human facial development, in which PAX3
mutations lead to Waardenburg syndrome types I and III,
a rare (1/40,000) disorder characterized clinically by the
association of craniofacial dysmorphism, pigmentation
defects, and severe sensorineural congenital hearing im-
pairment (Tassabehji et al. 1993). This congenital disor-
der is likely to be caused by defective function of the
embryonic neural crest. In contrast, no human develop-
mental syndrome has been associated so far with muta-
tions in PAX7.
Spontaneous mutations in the Pax3 locus were first
identified and analyzed 50 years ago (Auerbach 1954),
and these deficiencies have been well documented in the
mouse embryo since then. Our Pax3nlacZ allele illus-
trates the deficiencies of the mutant embryo in many
sites where Pax3 is expressed: for example, in the devel-
oping neural tube, where Pax7 and Pax3 expression over-
laps in the alar plate. At this level, Pax3 transcription is
initiated at the neural plate stage and precedes that of
Pax7, which begins after neural tube closure (Jostes et al.
1990; Goulding et al. 1991). In addition, Pax7 is never
expressed in the roof plate. As a consequence, Pax3-de-
ficient mice exhibit neural tube defects such as spina
bifida and, with a lower frequency, exencephaly (Fig. 4).
Migrating neural crest cells in the head and body also
express Pax3 (Fig. 6A,C) as do neural crest cell deriva-
tives, such as melanocytes or the dorsal root ganglia. In
the absence of Pax3, there is almost no neural crest cell
migration from the dorsal neural tube in the trunk,
which leads to the almost complete absence of the pe-
ripheral nervous system and melanocytes (Tremblay
et al. 1995). The severity of the neural crest cell defects
increases along the rostrocaudal axis (Auerbach 1954),
although the molecular basis remains unclear. Because
Pax7 is expressed in anterior neural crest cells (Mansouri
et al. 1996b), it is possible that an anteroposterior gradi-
ent of Pax7 expression underlies this phenotype. Our
demonstration that Pax7 can replace Pax3 in the dorsal
neural tube and neural crest points to a common func-
tion for the two proteins and suggests its pre-existence in
the nervous system before the Pax3/7 gene duplication
at the onset of vertebrate evolution rather than coevolu-
tion. This may also apply to the neural crest function
because the Amphi-Pax3/7 is expressed in a cellular
population comparable to the premigratory neural crest
cells of vertebrates (Holland et al. 1999).
Pax3 and Pax7 functions in
somatogenesis and myogenesis
In addition to its role in the nervous system and in neu-
ral crest, Pax3 has important functions in somitogenesis.
This role has been acquired during evolution because the
primitive Pax3/7 gene is not expressed in mesoderm.
Again, it is in Amphioxus that this function is observed
(Holland et al. 1999). Our results demonstrate that Pax7
can efficiently substitute for Pax3 during somite seg-
mentation and in the development and maintenance of
the dermomyotome. Furthermore, myogenesis proceeds
normally in the trunk in the absence of Pax3. This there-
fore suggests that during vertebrate evolution, Pax7 has
retained the biochemical activity that is now mainly ex-
ercised by Pax3 during somitogenesis in the mouse.
Pax3 also has a critical function in appendicular
muscle formation and in that of other muscles, such as
those derived from the hypoglossal chord, that also de-
pend on the long-range migration of muscle progenitor
cells from the hypaxial somite. Pax7 is not expressed in
these migrating cells and is only transcribed later as limb
muscles develop. It was therefore not clear whether the
Figure 8. Requirement for Pax3 function
at several steps of limb muscle formation.
Successive stages are depicted schemati-
cally on the left on a transverse section at
the forelimb level. Defects at these differ-
ent stages (formation of the hypaxial der-
momyotome, delamination, migration and
proliferation of muscle progenitor cells,
and formation of proximal and distal, dor-
sal and ventral, muscle masse) with differ-
ent Pax3 alleles are indicated (+, normal;
−, absent or reduction is indicated). (MPC)
Myogenic progenitor cells; (NT) neural
tube; (Nc) notochord; (Sc) sclerotome.
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Pax3-mutant phenotype reflected the lack of Pax7 in
these cells. The fact that the hypaxial dermomyotome is
lost in the mutant further complicates any interpreta-
tion. However, when Pax7 replaces Pax3, the hypaxial
dermomyotome, which is the source of the migratory
cells, is present, and in this situation it is now possible to
analyze the role of Pax7 in these myogenic progenitor
cells. The results demonstrate that Pax7 is not equiva-
lent to Pax3 in the context of limb muscle formation,
and this also applies to other muscles that depend on
long-range migration, such as the diaphragm or those
derived from the hypoglossal chord.
Both Pax3 and Pax7 genes may generate more than one
transcript and protein isoform (see Ziman and Kay 1998;
Barber et al. 1999), although it has not been shown that
these are functionally significant. Because a sequence
encoding a single isoform of Pax7 was inserted into the
Pax3 locus, it is formally possible that other isoforms
of Pax7 may be able to perform specific functions such
as those required for limb muscle formation. The iso-
form that was targeted to Pax3 lacks the first of three
putative ATGs, and thus potentially lacks 10 N-term-
inal amino acid residues. It has been proposed that the
first 90 N-terminal amino acids of Pax3 may contri-
bute to repressor activity (Chalepakis et al. 1994), but
transactivation experiments showed no difference be-
tween the activity of this isoform of Pax7 and Pax3
(data not shown), suggesting that the repression domain
does not include these potential N-terminal residues of
the Pax7 protein. In addition, we have previously shown
that Pax3 acts genetically as a transcriptional activa-
tor during limb muscle formation (Relaix et al. 2003).
The stability of the Pax7 transcript or protein produced
from the knock-in allele may be different from that of
endogenous Pax3, leading to altered relative protein lev-
els, which might affect limb muscle formation if this
is more sensitive to dose than other sites of myogen-
esis. However, the nLacZ reporter gene expression and
the antibody staining shown here would suggest that
any differences in mRNA or protein levels between
the Pax3nLacZ or the Pax3Pax7–ILZ alleles are probably
minor.
Pax3 controls several steps
in limb muscle development
Pax3Pax7–ILZ/Sp embryos (with one copy of Pax7 replac-
ing both Pax3 alleles) and Pax3Pax7–ILZ/Pax7–ILZ embryos
(with two copies of Pax7 replacing both Pax3 alleles)
have graded defects in limb formation, showing that
Pax7 acts as a hypomorph of Pax3, revealing previously
hidden functions for Pax3 in this process (Fig. 8). Defects
in hypoglossal chord formation also clearly illustrate this
hypomorphic activity of the Pax7 replacement allele.
As a result of early apoptosis, Pax3-deficient embryos
lack the hypaxial dermomyotome from which the mi-
grating myogenic progenitor cells delaminate. The role
of Pax3 in maintaining this structure is similar to the
situation in the dorsal neural tube, where Pax3 has a role
in blocking p53-mediated apoptosis (Pani et al. 2002).
Because the hypaxial somite is intact in Pax3Pax7–ILZ/Sp
or Pax3Pax7–ILZ/Pax7–ILZ embryos, Pax7 clearly rescues
this early function, suggesting that, similarly to Pax3
(Borycki et al. 1999; Relaix et al. 2003), it may target
anti-apoptotic genes.
In the presence of an intact hypaxial dermomyotome,
myogenic progenitor cells expressing two Pax7 alleles in
place of Pax3 will form apparently normal skeletal mus-
culature in the hindlimb, whereas in the forelimb this is
already compromised. In the presence of only one Pax7
replacement allele, myogenesis in the hindlimb is also
defective and there is no muscle formation in the fore
limb. This anterior/posterior difference may be related to
the developmental timing of limb formation, with a
higher threshold for Pax3/7 activity initially. In addition,
embryonic limbs differ in the expression of genes such as
Tbx4 and 5, expressed in fore- and hindlimbs, respec-
tively (Gibson-Brown et al. 1996). Such differences in the
regulatory environment may affect the behavior of myo-
genic cells. The Hox code is another potential modula-
tor of myogenesis on the anterior/posterior axis (Alvares
et al. 2003).
Myogenic progenitor cells delaminate from the epithe-
lium of the dermomyotome and then migrate into the
limb field. Some delamination occurs, even in situations
in which there is no subsequent migration to the limb, as
seen in Pax3Pax7–ILZ/Sp embryos. There is therefore un-
coupling between the two processes. When limb muscle
formation occurs but is compromised, migration of
muscle progenitor cells appears to be retarded, which
may explain why the most distal palm muscles are lack-
ing in the hindlimbs of Pax3Pax7–ILZ/Sp embryos. How-
ever, in this situation some proximal muscles are also no
longer detectable, and there is an overall reduction in
both delamination and migration. A key effector of these
processes is the tyrosine kinase receptor, Met (Yang et al.
1996). In Pax3Pax7–ILZ/Sp embryos, c-met expression is
barely detectable hypaxially. A few cells are still able to
delaminate from the hypaxial dermomyotome, suggest-
ing that some residual Met signaling activity is still pres-
ent. However, the myogenic progenitor cells are unable
to migrate to invade the forelimb bud in these embryos,
indicating that a threshold level of Met is not reached
and suggesting that in the absence of efficient Met sig-
naling the cells that have delaminated cannot enter the
limb. These results further confirm the role of Pax3 in
the transcriptional activation of c-met (Epstein et al.
1996; Relaix et al. 2003) and demonstrate that Pax7 per-
forms this function much less efficiently. In addition,
our data show that a Pax7-VP16 protein can transacti-
vate a c-met reporter construct as well if not better than
the equivalent Pax3 fusion protein, indicating that it
binds efficiently. Because Pax3 and Pax7 alone are very
poor transcriptional activators, the functional difference
between Pax3 and Pax7 in c-met activation probably lies
in the recruitment of specific coactivator(s). Mutants for
the Gab1 adapter protein, an important mediator of Met
signaling, display limb muscle phenotypes similar to
those observed in Pax3Pax7–ILZ/Pax7–ILZ embryos (Sachs
Replacement of Pax3 by Pax7
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et al. 2000), suggesting that reduced c-met expression
mainly accounts for the limb muscle phenotype. Surpris-
ingly, c-met expression in the epaxial domain of the so-
mite is maintained in the presence of only one replace-
ment allele of Pax7. In Pax3-mutant mice the epaxial,
similarly to the hypaxial, extremity of the dermomyo-
tome is lost, and it is therefore not possible to conclude
about Pax3 regulation of this site of c-met expression.
However, in a gain-of-function mutant due to the pres-
ence of PAX3–FKHR, c-met is also up-regulated in this
domain (Relaix et al. 2003). Epaxial expression may also
depend on transcriptional regulators other than Pax3.
The role of Met signaling in the epaxial somite is not
clear, because the mutants do not have epaxial defects
(Bladt et al. 1995; Dietrich et al. 1999; Relaix et al. 2003).
This expression may be an evolutionary remnant of an
epaxial function of Met lost in amniotes, required, for
example, in dorsal fin formation of fish.
Myogenic progenitor cells in the limb proliferate, and
we show that the effects of a reduction in the number of
these cells that reach the limb bud is compounded by a
defect in proliferation (but not apoptosis) in the presence
of a Pax7 replacement allele. Met plays a role in tumori-
genesis and proliferation (Danilkovitch-Miagkova and
Zbar 2002; Trusolino and Comoglio 2002). In skeletal
muscle it has been implicated in the proliferation of fe-
tal, but not embryonic, myoblasts (Maina et al. 1996). In
addition to c-met, Pax3 probably targets other genes in-
volved in cell cycle regulation, as suggested by microar-
ray analysis on cultured cells (Khan et al. 1999; Mayanil
et al. 2001).
When limb muscle masses are reduced, on Pax3 re-
placement by Pax7, differentiation appears to proceed
normally, with activation of MyoD, a Pax3 target (Taj-
bakhsh et al. 1997; Relaix et al. 2003). It has been suggested
that Pax3 itself is not required for muscle differentiation
in the limb, based on transplantation experiments of
myogenic progenitor cells from Sp-mutant embryos into
the chick wing bud where they formed muscle (Daston
et al. 1996). It is striking that although they are reduced
in size, the overall patterning of muscle masses is re-
tained, as seen in the hindlimbs of Pax3Pax7–ILZ/Sp mice.
Some muscles are, however, lost. Loss of distal muscles
may reflect a failure of migrating progenitor cells to
reach these locations, as discussed. More surprising is
the apparent loss of specific proximal muscles. It is pos-
sible that this reflects a reduction in muscle progenitor
cells at this site, due to migration and proliferation de-
fects, below a threshold level required for a community
effect, leading to skeletal muscle formation (Cossu and
Borello 1999; Buckingham 2003).
Pax3/7 function in myogenic progenitor
cells and evolutionary history of
vertebrate appendicular muscles
In the vertebrate clade, the ancestral mechanism for ap-
pendicular muscle development involves the direct ex-
tension of the epithelial (dermo)myotome into the fin or
limb bud. Subsequently, a mechanism for the delamina-
tion and migration of muscle progenitor cells (Haines
and Currie 2001) may have evolved in teleost fishes, just
prior to tetrapod radiation (Neyt et al. 2000). However, as
pointed out by Galis (2001), there is a highly mosaic
distribution of these characters in the vertebrate clade as
well as the presence of an intermediate mode (with myo-
tomal extension then short range migration) in some rep-
tiles and amphibians, suggesting that evolution of verte-
brate appendicular muscle formation is complex. Our
observation that Pax7 only partially fulfills the functions
of Pax3 in limb muscle formation, whereas it performs
the role of Pax3 in somitogenesis and trunk myogenesis
as well as in the neural tube and neural crest, is consis-
tent with the later evolution of this myogenic mode and
demonstrates the central importance of Pax3 in this de-
velopment. Two possible hypotheses can be formulated
for the hypomorphic Pax7 activity in appendicular
muscle development: (1) either this Pax3 function
evolved independently after Pax3/7 duplication, reusing
biochemical functions already partially present in the
Pax3/7 protein (e.g., the ancestral function in myotomal
ventral body wall formation or myotomal extension into
the fin or limb bud), or (2) this function was already
present in the Pax3/7 protein before gene duplication and
was partially lost during independent Pax7 evolution in
vertebrates. The acquisition of molecular properties
such as interaction with cofactors that distinguish Pax3
from Pax7 and the ancestral Pax3/Pax7 sequence was
therefore probably an essential prerequisite for the evo-
lution of vertebrate appendicular muscle.
Materials and methods
Targeting vectors and mice
The targeting construct is derived from one which was previ-
ously reported (Relaix et al. 2003). Cloning details are available
on request. Briefly, the Pax3DsRed(Pax7–ILZ) allele contains 2.4 kb
of 5 genomic region, replacing the coding sequence of exon 1
and 4 kb of 3 sequence containing exons 2–4. The genomic
sequences surround a Floxed Dsred-FRT-Puro cassette followed
by 1.8 kb mouse Pax7 cDNA (kindly provided by M. Rudnicki
[Ottawa Health Research Institute, Ottawa, Canada], accession
no. NM011039; we confirmed by sequencing that the Pax7 se-
quence corresponds to that originally published [Seale et al.
2000], which starts with two consecutive ATGs, as putative
translational start sites), then an IRESnLacZ cassette sur-
rounded by FRT sites. In addition, a PGK-DTA cassette encod-
ing the A subunit of the Diphtheria toxin gene (Meilhac et al.
2003) was inserted 5 of the constructs to allow negative selec-
tion in ES cells. The targeting vector was electroporated in
CK35 ES cells (Kress et al. 1998). ES cells were selected and
screened for recombination events by Southern blot analysis
using EcoRV digests and a 5-flanking probe and were verified by
using 3 and internal probes (Fig. 2). Targeted ES cells were
recovered with a 0.5%–1% frequency and injected into blasto-
cysts to generate chimaeras. Germline-transmitted alleles were
identified by the classical Splotch heterozygote phenotype (lack
of melanocyte colonization of the belly), and by PCR or by
Southern blotting. Cre transgenic mice have been described pre-
viously (Lallemand et al. 1998). Generation of the P34TKZ line
was reported previously (Relaix et al. 2003).
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X-Gal staining, histology, immunohistochemistry,
whole-mount in situ hybridization, and
whole-mount immunohistochemistry
Mouse embryos were collected after natural overnight matings;
for staging, fertilization was considered to take place at 6 a.m.
For X-Gal staining, dissected embryos were fixed for 10–30 min
(depending on the stage) with 4% paraformaldehyde (PAF) in
PBS, on ice. Embryos were rinsed twice with PBS and then
stained with X-Gal (Roche), using 0.4 mg/mL X-Gal in 2 mM
MgCl2, 0.02% NP-40, 0.1 M PBS (pH 7.5), 20 mM K4Fe(CN)6,
and 20 mM K3Fe(CN)6 for 4–16 h at 37°C, with shaking. Em-
bryos were rinsed in PBS and postfixed overnight in 4% PAF. For
histological analysis, sections (12 µm) were prepared from X-Gal
colored embryos and stained with eosin according to standard
procedures. Genotyping for whole-mount in situ hybridization
was carried out by PCR or X-Gal staining in X-Gal + 0.2% PAF
for 30 min following 1–2-h fixation in 4% PAF, on ice. When
light color had developed (20–30), embryos were rinsed in PBS
and postfixed overnight in 4% PAF. Whole-mount in situ hy-
bridization with digoxigenin-labeled riboprobes was performed
as described (Tajbakhsh et al. 1997). The MyoD riboprobe was as
previously described (Tajbakhsh et al. 1997). The c-met probe
was kindly provided by C. Birchmeier (Max Delbrück Center for
Molecular Medicine, Berlin, Germany; Bladt et al. 1995). The
Pax7 probe was obtained from M. Rudnicki (Seale et al. 2000).
Fluorescent coimmunohistochemistry was carried out as de-
scribed previously (Relaix et al. 2003), using the following an-
tibodies : polyclonal anti--galactosidase (Molecular Probe. Di-
luted 1:200), polyclonal anti-MHC (obtained from G. Cossu,
Stem Cell Research Institute, H.S. Raffaele, Milan, Italy, 1:200),
monoclonal anti-phospho histone H3 (Cell Signaling, 1:100),
monoclonal anti--Gal (Sigma, 1:200), monoclonal anti-Pax7
(Developmental Studies Hybridoma Bank, 1:100), monoclonal
anti-Pax3 (kindly provided by M. Bronner-Fraser, California In-
stitute of Technology, Pasadena, CA, 1:100), monoclonal anti-
desmin (Dako, 1:200), and polyclonal anti-active Caspase 3
(Pharmingen, 1:250).
Transient transfection experiments
The human c-met promoter (3 kb) was amplified by PCR from
mouse genomic DNA and cloned in front of the TK-nLacZpA
plasmid (Relaix et al. 2003). Transient transfections, -Gal, and
luciferase assays were performed as described previously (Relaix
et al. 2003).
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